Navigating the Fine Line Between the Bad and Worse: The Issue Is Not the Number, and the Message Is Not “All or Nothing”

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 30, Issue 5, 2016, Pages 1159-1162

  Calcaterra, Domenico ^a   Renfro, Leslie A ^b   Shander, Aryeh ^c  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FOLIC ACID; HEMOGLOBIN; IRON;

ANEMIA; AORTA SURGERY; BLOOD TRANSFUSION; CAUSE OF DEATH; CLINICAL OUTCOME; COHORT ANALYSIS; CRITICALLY ILL PATIENT; EDITORIAL; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MORBIDITY; MORTALITY RATE; MORTALITY RISK; OPEN HEART SURGERY; OPERATIVE BLOOD LOSS; PEROPERATIVE CARE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPENSITY SCORE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGICAL MORTALITY; SURVIVAL RATE; BLOOD;

ANEMIA; BLOOD TRANSFUSION; HEMOGLOBINS; HUMANS;

EID: 84991061368     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2016.06.029     Document Type: Editorial

References (34)

1. 1 Shander, A., Javidroozi, M., Ozawa, S., et al. What is really dangerous: Anaemia or transfusion?. Br J Anaesth 107:1 (2011), i41–i59.
2. 2 Hebert, P.C., Wells, G., Blajchman, M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340 (1999), 409–417.
3. 3 Curley, G.F., Shehata, N., Mazer, C.D., et al. Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: A systematic review and meta-analysis*. Crit Care Med 42 (2014), 2611–2624.
4. 4 Holst, L.B., Petersen, M.W., Haase, N., et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: Systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ, 350, 2015, h1354.
5. 5 Ripolles, M.J., Casans, F.R., Espinosa, A., et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion in critically ill patients and in patients with acute coronary syndrome: A systematic review, meta-analysis and trial sequential analysis. Minerva Anestesiol 82 (2016), 582–598.
6. 6 Patel, N.N., Avlonitis, V.S., Jones, H.E., et al. Indications for red blood cell transfusion in cardiac surgery: A systematic review and meta-analysis. Lancet Haematol 2 (2015), e543–e553.
7. 7 Fominskiy, E., Putzu, A., Monaco, F., et al. Liberal transfusion strategy improves survival in perioperative but not in critically ill patients. A meta-analysis of randomised trials. Br J Anaesth 115 (2015), 511–519.
8. 8 Wang, Y., Ji, H., Comparison of two different red blood cell transfusion thresholds on the short-term clinical outcomes of patients undergoing aortic surgery with deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 30 (2016), 1163–1166.
9. 9 Likosky, D.S., Al-Attar, P.M., Malenka, D.J., et al. Geographic variability in potentially discretionary red blood cell transfusions after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 148 (2014), 3084–3089.
10. 10 McQuilten, Z.K., Andrianopoulos, N., Wood, E.M., et al. Transfusion practice varies widely in cardiac surgery: Results from a national registry. J Thorac Cardiovasc Surg 147 (2014), 1684–1690.
11. 11 Shander, A., Puzio, T., Javidroozi, M., Variability in transfusion practice and effectiveness of strategies to improve it. J Cardiothorac Vasc Anesth 26 (2012), 541–544.
12. 12 Ferraris, V.A., Martin, J.P., Is limiting transfusion safe? The devil is in the details. J Thorac Cardiovasc Surg 150 (2015), 1032–1034.
13. 13 Hajjar, L.A., Vincent, J.L., Galas, F.R., et al. Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 304 (2010), 1559–1567.
14. 14 Martin, J.T., Ferraris, V.A., Blood conservation. Semin Thorac Cardiovasc Surg 27 (2015), 266–270.
15. 15 Moskowitz, D.M., McCullough, J.N., Shander, A., et al. The impact of blood conservation on outcomes in cardiac surgery: Is it safe and effective?. Ann Thorac Surg 90 (2010), 451–458.
16. 16 Murphy, G.J., Pike, K., Rogers, C.A., et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 372 (2015), 997–1008.
17. 17 Shander, A.S., Goodnough, L.T., Blood transfusion as a quality indicator in cardiac surgery. JAMA 304 (2010), 1610–1611.
18. 18 Ad, N., Holmes, S.D., Shuman, D.J., et al. Should asymptomatic patients discharged with lower hemoglobin expect worse outcomes after valve surgery?. J Thorac Cardiovasc Surg 150 (2015), 1322–1328.
19. 19 Whitman, G.J., Permissive anemia: How low should we go?. J Thorac Cardiovasc Surg 150 (2015), 1330–1331.
20. 20 Shander, A., Preoperative anemia and its management. Transfus Apher Sci 50 (2014), 13–15.
21. 21 Shander, A., Goodnough, L.T., Javidroozi, M., et al. Iron deficiency anemia–bridging the knowledge and practice gap. Transfus Med Rev 28 (2014), 156–166.
22. 22 Loor, G., Rajeswaran, J., Li, L., et al. The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both?. J Thorac Cardiovasc Surg 146 (2013), 1480–1487.
23. 23 Koch, C.G., Li, L., Sun, Z., et al. Magnitude of anemia at discharge increases 30-day hospital readmissions. J Patient Saf, 2014 September 2 [Epub ahead of print].
24. 24 Carson, J.L., Carless, P.A., Hebert, P.C., Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev, 4, 2012 CD002042.
25. 25 Schulz, K.F., Grimes, D.A., Multiplicity in randomised trials I: Endpoints and treatments. Lancet 365 (2005), 1591–1595.
26. 26 Najafi, M., Faraoni, D., Hemoglobin optimization and transfusion strategies in patients undergoing cardiac surgery. World J Cardiol 7 (2015), 377–382.
27. 27 Vincent, J.L., Indications for blood transfusions: Too complex to base on a single number?. Ann Intern Med 157 (2012), 71–72.
28. 28 Vincent, J.L., Which carries the biggest risk: Anaemia or blood transfusion?. Transfus Clin Biol 22 (2015), 148–150.
29. 29 Shander, A., Javidroozi, M., Blood conservation strategies and the management of perioperative anaemia. Curr Opin Anaesthesiol 28 (2015), 356–363.
30. 30 Goodnough, L.T., Shander, A., Patient blood management. Anesthesiology 116 (2012), 1367–1376.
31. 31 Shander, A., Hofmann, A., Isbister, J., et al. Patient blood management–the new frontier. Best Pract Res Clin Anaesthesiol 27 (2013), 5–10.
32. 32 Hessel, E.A., Levy, J.H., Guidelines for perioperative blood transfusion and conservation in cardiac surgery: Lessons and challenges. Anesth Analg 111 (2010), 1555–1559.
33. 33 Ferraris, V.A., Brown, J.R., Despotis, G.J., et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91 (2011), 944–982.
34. 34 Shander, A., Isbister, J., Gombotz, H., Patient blood management: The global view. Transfusion 56 (2016), S94–S102.